Scarica l'app Stockscreener
13.82
4.69%
-0.68
Dopo l'orario di chiusura:
13.92
0.10
+0.72%
Precedente Chiudi:
$14.50
Aprire:
$14.5
Volume 24 ore:
307.88K
Relative Volume:
1.08
Capitalizzazione di mercato:
$719.03M
Reddito:
-
Utile/perdita netta:
$-41.43M
Rapporto P/E:
-17.49
EPS:
-0.79
Flusso di cassa netto:
$-39.97M
1 W Prestazione:
+4.86%
1M Prestazione:
+9.42%
6M Prestazione:
+58.85%
1 anno Prestazione:
+78.55%
Intervallo 1D:
$13.59
$14.90
Intervallo di 1 settimana:
$12.26
$14.90
Portata 52W:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Confronta GHRS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
13.82 | 826.23M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2025-03-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-02-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-16 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Gh Research Plc Borsa (GHRS) Ultime notizie
What momentum shifts mean for GH Research PLCJuly 2025 Recap & Safe Capital Investment Plans - newser.com
GH Research Presents Promising GH001 Trial Data at ECNP 2025 - MSN
How GH Research PLC stock responds to policy changesWeekly Trend Report & Low Drawdown Momentum Ideas - newser.com
Using fundamentals and technicals on GH Research PLC2025 Valuation Update & Growth-Oriented Investment Plans - newser.com
Is GH Research PLC stock a buy in volatile marketsMarket Trend Report & Real-Time Price Movement Reports - newser.com
Is GH Research PLC stock a safe buy before earningsShort Setup & Advanced Technical Analysis Signals - newser.com
GH Research Unveils Promising GH001 Trial Data at ECNP 2025 - TipRanks
Real time alert setup for GH Research PLC performanceWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com
Is GH Research PLC stock attractive for income investorsJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
Has GH Research PLC found a price floor2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com
Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga
Is GH Research PLC stock cheap at current valuationDay Trade & AI Driven Stock Price Forecasts - newser.com
Combining machine learning predictions for GH Research PLCJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Needham Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq
Signal strength of GH Research PLC stock in tech scannersMarket Risk Report & Verified Short-Term Plans - newser.com
Can a trend reversal in GH Research PLC lead to recoveryRisk Management & Risk Managed Trade Strategies - newser.com
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress - GlobeNewswire
GH Research PLC stock momentum explainedMarket Sentiment Report & Free Daily Entry Point Trade Alerts - newser.com
GH Research Showcases Promising Depression Treatment at ECNP 2025 - TipRanks
GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress - Quiver Quantitative
No treatment-related SAEs: GH Research 6‑Month GH001 safety & psychoactive data for TRD at ECNP 2025 - Stock Titan
Will GH Research PLC stock outperform international peers2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
GH Research's (GHRS) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Market reaction to GH Research PLC’s recent newsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Can volume confirm reversal in GH Research PLCQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Does GH Research PLC qualify in momentum factor screeningMarket Activity Summary & Safe Investment Capital Preservation Plans - newser.com
Will GH Research PLC stock benefit from automationWall Street Watch & Low Drawdown Investment Ideas - newser.com
Gh Research Plc Azioni (GHRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):